Literature DB >> 21364027

What information should be required to support clinical "omics" publications?

Keith A Baggerly1, Kevin R Coombes.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21364027     DOI： 10.1373/clinchem.2010.158618

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  18 in total

1.  The evolving role of the pathologist in the management of lung cancer.

Authors:  Adi F Gazdar
Journal:  Lung Cancer Manag       Date:  2012

2.  Precision medicine for cancer patients: lessons learned and the path forward.

Authors:  Adi F Gazdar; John D Minna
Journal:  J Natl Cancer Inst       Date:  2013-08-20       Impact factor: 13.506

3.  FAST: FAST Analysis of Sequences Toolbox.

Authors:  Travis J Lawrence; Kyle T Kauffman; Katherine C H Amrine; Dana L Carper; Raymond S Lee; Peter J Becich; Claudia J Canales; David H Ardell
Journal:  Front Genet       Date:  2015-05-19       Impact factor: 4.599

Review 4.  Predicting outcomes in radiation oncology--multifactorial decision support systems.

Authors:  Philippe Lambin; Ruud G P M van Stiphout; Maud H W Starmans; Emmanuel Rios-Velazquez; Georgi Nalbantov; Hugo J W L Aerts; Erik Roelofs; Wouter van Elmpt; Paul C Boutros; Pierluigi Granone; Vincenzo Valentini; Adrian C Begg; Dirk De Ruysscher; Andre Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

Review 5.  Reuse of public genome-wide gene expression data.

Authors:  Johan Rung; Alvis Brazma
Journal:  Nat Rev Genet       Date:  2012-12-27       Impact factor: 53.242

6.  Clinical trials in the era of personalized oncology.

Authors:  Michael L Maitland; Richard L Schilsky
Journal:  CA Cancer J Clin       Date:  2011-10-27       Impact factor: 508.702

Review 7.  A structured approach to predictive modeling of a two-class problem using multidimensional data sets.

Authors:  Heidi Spratt; Hyunsu Ju; Allan R Brasier
Journal:  Methods       Date:  2013-01-12       Impact factor: 3.608

Review 8.  Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ.

Authors:  Hitchintan Kaur; Shihong Mao; Seema Shah; David H Gorski; Stephen A Krawetz; Bonnie F Sloane; Raymond R Mattingly
Journal:  Expert Rev Mol Diagn       Date:  2013-03       Impact factor: 5.225

Review 9.  Proteomics and metabolomics in renal transplantation-quo vadis?

Authors:  Rahul Bohra; Jacek Klepacki; Jelena Klawitter; Jost Klawitter; Joshua M Thurman; Uwe Christians
Journal:  Transpl Int       Date:  2012-11-21       Impact factor: 3.782

10.  More data, please!

Authors:  Keith Baggerly
Journal:  Clin Chem       Date:  2013-01-22       Impact factor: 8.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.